Estrogenic Activity in White and Red Wine Extracts
- 27 February 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 51 (7) , 1850-1857
- https://doi.org/10.1021/jf0259821
Abstract
Red wine is enriched in resveratrol, trans-3,5,4‘-trihydroxystilbene, a compound in grape skin that inhibits the development of pre-neoplastic lesions in mouse mammary tumor cells in culture and inhibits cancer cell proliferation in vitro. Grapes also contain other bioactive compounds including flavonoids, flavans, and anthocyanins. The estrogenic activities of extracts prepared from one white (Freie Weingärtner Wachau, Grüner Veltliner, Austria) and two red wines (Woodbridge, Cabernet Sauvignon, California; and Lenz Moser Prestige, Blaufränkisch Barrique, Austria) were examined and compared with those induced by estradiol (E2) and trans-resveratrol. First, the estrogenic activity of the wine extracts was evaluated in a yeast estrogen screen (YES) assay, in which yeast express copper-inducible estrogen receptor α (ERα) and an estrogen-response-element (ERE)-driven β-galactosidase reporter. In YES, the white wine extract showed no estrogenic activity. In contrast, both of the red wine extracts showed estrogenic activity equivalent to that of 0.2 nM E2. Similarly, the white wine extract showed no transcriptional activity with either ERα and ERβ in transiently transfected CHO-K1 cells. In contrast, both red wine extracts stimulated ERE-reporter activity in a concentration-dependent manner that was inhibited by 4-hydroxytamoxifen (4-OHT), indicating that the observed transcriptional activity was ER-mediated. The red wine extracts showed significantly higher ERβ versus ERα agonist activity. Resveratrol showed no agonist activity in YES but activated ERα and ERβ in CHO-K1 cells in a concentration-dependent manner that was inhibited by 4-OHT. This indicates that resveratrol requires mammalian cell components that are absent in yeast for estrogen agonist activity, whereas the estrogenic activity of wine extracts is directly through ERα and does not require mammalian cell factors such as coactivators. The estrogenic activity in red wine found by using YES indicates that estrogenic compounds other than resveratrol are present. Chemical analysis clearly showed that the trans-resveratrol content of the red wine extracts was 1 order of magnitude below the detection limit for YES assay. Keywords: Estrogen receptor; estrogen; resveratrol; phytoestrogen; transcriptionKeywords
This publication has 29 references indexed in Scilit:
- Molecular Determinants for the Tissue Specificity of SERMsScience, 2002
- Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor αMolecular and Cellular Endocrinology, 2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Comparison of transcriptional synergy of estrogen receptors α and β from multiple tandem estrogen response elementsMolecular and Cellular Endocrinology, 2000
- Estrogen receptor interaction with co-activators and co-repressors☆Steroids, 2000
- Meetings: Conferences.Analytical Chemistry, 1999
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Method To Assay the Concentrations of Phenolic Constituents of Biological Interest in WinesAnalytical Chemistry, 1996
- Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonistsThe Journal of Steroid Biochemistry and Molecular Biology, 1992